Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Encore Wire (NASDAQ:WIRE) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Encore Wire will report an earnings per share (EPS) of $2.94.

Benzinga

If You Invested $1000 In Teradyne 5 Years Ago, Here's How Much You Would Have Today

Teradyne (NASDAQ:TER) has outperformed the market over the past 5 years by 12.45% on an annualized basis producing an average annual return of 24.31%. Currently, Teradyne has a market capitalization of $17.19 billion.

Benzinga

A Preview Of Haynes International's Earnings

Haynes International (NASDAQ:HAYN) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Haynes International will report an earnings per share (EPS) of $0.52.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Outlook For MidWestOne Financial Gr

MidWestOne Financial Gr (NASDAQ:MOFG) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that MidWestOne Financial Gr will report an earnings per share (EPS) of $0.79.

Benzinga

Looking Into Wynn Resorts Limited's Recent Short Interest

Wynn Resorts Limited's (NASDAQ:WYNN) short percent of float has fallen 20.49% since its last report. The company recently reported that it has 5.16 million shares sold short, which is 4.89% of all regular shares that are available for trading.

Benzinga

Rhythm Pharmaceuticals Q1 2022 Earnings Conference Call On May 3, 2022 At 08:30 AM ET

Rhythm Pharmaceuticals (NASDAQ:RYTM) will host a conference call at 08:30 AM ET on May 3, 2022, to discuss Q1 2022 earnings results. How to Attend Rhythm Pharmaceuticals (RYTM) Conference Call Follow this link to access the live webcast.

Benzinga

Markets Finish Marginally Higher As Earnings Reports Continue To Roll

U.S. indices traded slightly higher for the session as stocks rebounded following a sharp sell-off Tuesday amid continued concerns over the economic impacts of Fed rate hikes, the Russia-Ukraine conflict and recent earnings reports.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Here's How Much You Would Have Made Owning Ross Stores Stock In The Last 10 Years

Ross Stores (NASDAQ:ROST) has outperformed the market over the past 10 years by 1.0% on an annualized basis producing an average annual return of 12.52%. Currently, Ross Stores has a market capitalization of $35.70 billion.

Benzinga

Blueprint Medicines Q1 2022 Earnings Conference Call On May 3, 2022 At 08:30 AM ET

Blueprint Medicines (NASDAQ:BPMC) will host a conference call at 08:30 AM ET on May 3, 2022, to discuss Q1 2022 earnings results.

Benzinga

HC Wainwright & Co. Maintains Buy Rating for Sigma Labs: Here's What You Need To Know

HC Wainwright & Co. has decided to maintain its Buy rating of Sigma Labs (NASDAQ:SGLB) and lower its price target from $4.00 to $3.00. Shares of Sigma Labs are trading down 12.34% over the last 24 hours, at $1.56 per share.

Benzinga

UBS Maintains Buy Rating for Alphabet: Here's What You Need To Know

UBS has decided to maintain its Buy rating of Alphabet (NASDAQ:GOOGL) and lower its price target from $3850.00 to $3600.00. Shares of Alphabet are trading down 3.63% over the last 24 hours, at $2286.75 per share. A move to $3600.00 would account for a 57.43% increase from the current share…

Benzinga

JMP Securities Maintains Market Outperform Rating for Goosehead Insurance: Here's What You Need To Know

JMP Securities has decided to maintain its Market Outperform rating of Goosehead Insurance (NASDAQ:GSHD) and lower its price target from $140.00 to $130.00. Shares of Goosehead Insurance are trading up 5.59% over the last 24 hours, at $55.66 per share.

Benzinga

Susquehanna Maintains Positive Rating for Texas Instruments: Here's What You Need To Know

Susquehanna has decided to maintain its Positive rating of Texas Instruments (NASDAQ:TXN) and lower its price target from $230.00 to $215.00. Shares of Texas Instruments are trading up 0.66% over the last 24 hours, at $169.56 per share.

Benzinga

Wedbush Maintains Outperform Rating for Microsoft: Here's What You Need To Know

Wedbush has decided to maintain its Outperform rating of Microsoft (NASDAQ:MSFT) and lower its price target from $375.00 to $340.00. Shares of Microsoft are trading up 5.64% over the last 24 hours, at $285.46 per share. A move to $340.00 would account for a 19.11% increase from the current share…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

B. Riley Securities Maintains Neutral Rating for Enphase Energy: Here's What You Need To Know

B. Riley Securities has decided to maintain its Neutral rating of Enphase Energy (NASDAQ:ENPH) and raise its price target from $155.00 to $171.00. Shares of Enphase Energy are trading up 8.49% over the last 24 hours, at $166.90 per share.

Benzinga

Truist Securities Maintains Buy Rating for Alphabet: Here's What You Need To Know

Truist Securities has decided to maintain its Buy rating of Alphabet (NASDAQ:GOOGL) and lower its price target from $3600.00 to $3500.00. Shares of Alphabet are trading down 3.63% over the last 24 hours, at $2286.75 per share.

Benzinga

Mizuho Maintains Neutral Rating for Texas Instruments: Here's What You Need To Know

Mizuho has decided to maintain its Neutral rating of Texas Instruments (NASDAQ:TXN) and lower its price target from $190.00 to $175.00. Shares of Texas Instruments are trading up 0.66% over the last 24 hours, at $169.56 per share.

Benzinga

Rosenblatt Maintains Sell Rating for Warner Bros.Discovery: Here's What You Need To Know

Rosenblatt has decided to maintain its Sell rating of Warner Bros.Discovery (NASDAQ:WBD) and lower its price target from $20.00 to $18.00. Shares of Warner Bros.Discovery are trading down 4.39% over the last 24 hours, at $18.96 per share.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Barclays Maintains Equal-Weight Rating for AGNC Investment: Here's What You Need To Know

Barclays has decided to maintain its Equal-Weight rating of AGNC Investment (NASDAQ:AGNC) and lower its price target from $15.00 to $13.00. Shares of AGNC Investment are trading up 0.77% over the last 24 hours, at $11.15 per share.

Benzinga

Wolfe Research Maintains Outperform Rating for Microsoft: Here's What You Need To Know

Wolfe Research has decided to maintain its Outperform rating of Microsoft (NASDAQ:MSFT) and raise its price target from $330.00 to $350.00. Shares of Microsoft are trading up 5.63% over the last 24 hours, at $285.43 per share.

Benzinga

SVB Leerink Maintains Outperform Rating for Exact Sciences: Here's What You Need To Know

SVB Leerink has decided to maintain its Outperform rating of Exact Sciences (NASDAQ:EXAS) and lower its price target from $130.00 to $95.00. Shares of Exact Sciences are trading up 7.86% over the last 24 hours, at $63.24 per share.

Benzinga

Canaccord Genuity Maintains Buy Rating for Alphabet: Here's What You Need To Know

Canaccord Genuity has decided to maintain its Buy rating of Alphabet (NASDAQ:GOOGL) and lower its price target from $3500.00 to $3300.00. Shares of Alphabet are trading down 3.63% over the last 24 hours, at $2286.75 per share.

Benzinga

Credit Suisse Maintains Outperform Rating for Alphabet: Here's What You Need To Know

Credit Suisse has decided to maintain its Outperform rating of Alphabet (NASDAQ:GOOGL) and lower its price target from $3450.00 to $3400.00. Shares of Alphabet are trading down 3.63% over the last 24 hours, at $2286.75 per share.

Benzinga

Keybanc Maintains Overweight Rating for CareTrust REIT: Here's What You Need To Know

Keybanc has decided to maintain its Overweight rating of CareTrust REIT (NASDAQ:CTRE) and lower its price target from $25.00 to $23.00. Shares of CareTrust REIT are trading down 1.86% over the last 24 hours, at $16.32 per share.

Benzinga

Jefferies Maintains Buy Rating for Alphabet: Here's What You Need To Know

Jefferies has decided to maintain its Buy rating of Alphabet (NASDAQ:GOOGL) and lower its price target from $3600.00 to $3400.00. Shares of Alphabet are trading down 3.63% over the last 24 hours, at $2286.75 per share. A move to $3400.00 would account for a 48.68% increase from the current share…

1 … 558 559 560 561

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.